Cannabidiol: pharmacology and therapeutic targets

SC Britch, S Babalonis, SL Walsh - Psychopharmacology, 2021 - Springer
Rationale Cannabidiol (CBD) products lacking regulatory approval are being used to self-
treat a myriad of conditions and for their unsubstantiated health benefits. The scientific …
被引用次数：208 相关文章

Cannabidiol: pharmacology and therapeutic targets.

SC Britch, S Babalonis, SL Walsh - Psychopharmacology, 2021 - search.ebscohost.com
Rationale: Cannabidiol (CBD) products lacking regulatory approval are being used to self-
treat a myriad of conditions and for their unsubstantiated health benefits. The scientific …

Cannabidiol: pharmacology and therapeutic targets

SC Britch, S Babalonis, SL Walsh - Psychopharmacology, 2021 - pubmed.ncbi.nlm.nih.gov
Rationale Cannabidiol (CBD) products lacking regulatory approval are being used to self-
treat a myriad of conditions and for their unsubstantiated health benefits. The scientific …

Cannabidiol: Pharmacology and therapeutic targets.

SC Britch, S Babalonis, SL Walsh - Psychopharmacology, 2021 - psycnet.apa.org
Rationale: Cannabidiol (CBD) products lacking regulatory approval are being used to self-
treat a myriad of conditions and for their unsubstantiated health benefits. The scientific …

Cannabidiol: pharmacology and therapeutic targets.

SC Britch, S Babalonis, SL Walsh - Psychopharmacology, 2021 - go.gale.com
Rationale Cannabidiol (CBD) products lacking regulatory approval are being used to self-
treat a myriad of conditions and for their unsubstantiated health benefits. The scientific …

Cannabidiol: pharmacology and therapeutic targets

SC Britch, B Shanna, SL Walsh - Psychopharmacology, 2021 - search.proquest.com
Objectives This paper reviews the molecular targets, pharmacokinetics, and safety and
abuse liability of CBD; additionally, the extant evidence on its potential therapeutic effects for …

Cannabidiol: pharmacology and therapeutic targets.

SC Britch, S Babalonis, SL Walsh - Psychopharmacology, 2020 - europepmc.org
Objectives This paper reviews the molecular targets, pharmacokinetics, and safety and
abuse liability of CBD; additionally, the extant evidence on its potential therapeutic effects for …
[HTML] nih.gov

[HTML][HTML] Cannabidiol: Pharmacology and Therapeutic Targets

SC Britch, S Babalonis, SL Walsh - Psychopharmacology, 2021 - ncbi.nlm.nih.gov
Cannabidiol (CBD) products lacking regulatory approval are being used to self-treat a
myriad of conditions and for its unsubstantiated health benefits. The scientific evidence …